Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.
about
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent responseEfficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.What do patients want from acute migraine treatment?Transdermal delivery of sumatriptan for the treatment of acute migraineMechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Indolealkylamines: biotransformations and potential drug-drug interactionsTherapies in development for the treatment of migraine.Clinical profile and practice experience of almotriptan.Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.Eletriptan: a review and new perspectives.Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a commentAlmotriptan in the treatment of migraine.Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study.Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.Drug safety in acute migraine treatment.The influence of genetic constitution on migraine drug responses.Effect of N-salicyloyltryptamine (STP), a novel tryptamine analogue, on parameters of cell viability, oxidative stress, and immunomodulation in RAW 264.7 macrophages.Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.Dose range-finding studies with frovatriptan in the acute treatment of migraine.The triptans.Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptanMethod development and validation of almotriptan in human plasma by HPLC tandem mass spectrometry: application to pharmacokinetic study.Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route.Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.Alpha[11C] methyl-L-typtophan positron emission tomography in patients with alternating hemiplegia of childhood.CNS effects of sumatriptan and rizatriptan in healthy female volunteers.[What takes place in the receptor? Ligand-receptor interaction in 5-HT agonists].[In the pipeline. Triptans--new developments].Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.Pharmacokinetics of frovatriptan in adolescent migraineurs.Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.17-β-Estradiol induces spreading depression and pain behavior in alert female rats.Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.Adding NSAIDs to triptans: could less be more?Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract.OCT1 mediates hepatic uptake of sumatriptan and loss-of-functionOCT1polymorphisms affect sumatriptan pharmacokinetics
P2860
Q28074159-4B98E962-9215-49A5-B9D6-BB67326D4D61Q33671824-72AC3F33-35E6-45ED-A17F-40C08BA93CE3Q34375878-D7058549-A5DF-4F12-A481-BCBEF22A0374Q34619206-6D7917E2-B711-4C4A-A86A-D72ECE673B8FQ34633457-2AEBC7C1-8F0B-478A-AD6B-7BEA62F7A421Q34775667-86C3527E-5BBE-4E18-8EF2-A9FB4B42F238Q35011915-D88A5B68-5F23-4E05-B399-6A75B2905C00Q35982145-57233575-319D-4C83-AF64-5EA7FCBD3AFAQ36373560-741DC00F-874C-4DB0-B241-000F075CB28FQ36641480-1E6A0C14-2868-45D5-BF85-16AB835A1819Q36978875-B6A5F905-BCED-4D63-BAAC-F5B85A31CF60Q37129812-4EBC75B2-C240-4BF5-BEAF-81A03974D509Q37271453-15618F5C-AD16-4065-833E-B305909567DDQ37818258-F9C51520-0E43-4ECB-B0E3-21509496077EQ38378898-83E8E33B-73BE-401B-A80D-F2B152C3D4CBQ38949801-DAB139D4-B89C-42EB-BCD8-B088D0EE2A3EQ39162721-09E1784E-807D-49A9-83BA-81A5CA08DDAAQ39276728-9C86669F-6683-45C7-9ED8-486423684703Q39365280-C73EB68D-03B1-4DB4-BCD4-01142E238195Q39406672-B547A351-8D2C-4C83-BE9A-7C3E07A8D113Q39983756-F62C6736-D982-4727-9495-0AE78C6467EAQ41500403-31564EAA-40C1-41C5-9CDB-87C8833BBECCQ42122554-103C7B9C-DDA1-46FD-85A7-3C34F3D3A9AEQ42738044-99551D76-AE0A-4648-A5C9-5BFA77E57E4FQ43967358-EBCE04F7-EF08-47CD-BE23-A7D140578104Q44043945-DE08F289-1366-48B7-B988-92DB9554CF05Q44051817-0C638994-65DC-4E2D-9583-99438D901E73Q44171184-B69B12EC-7EE8-458B-9F53-DEAD6A667ED4Q44171192-1C4D6339-D663-4A9B-9C01-02D3FB21B46AQ44700406-79FBFB18-6FD1-4782-94A4-3942D860BA93Q44805088-7447FD69-5D4B-4305-903D-F12A9B464451Q45040981-3610781D-51AF-4079-97A0-BB749A6523F7Q46076879-CD41886B-722B-4E83-96CE-AF15B66A0CE0Q47548932-FE45B8F2-BA90-422C-93CB-B206082EE8EBQ49873285-8F2D9E90-5778-4023-A463-9F071ACE4797Q50350695-D9FF83F7-9058-456A-ADE9-6B553972B2C8Q54443866-F9DACBB1-4BA1-4C1B-A426-A6EA2C10A032Q54480739-DC2A78E4-8DEC-4403-8DE4-115968AC21F5Q57988151-6192E97B-D23D-4EB6-8CFE-C8A42056A97A
P2860
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@ast
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@en
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@nl
type
label
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@ast
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@en
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@nl
prefLabel
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@ast
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@en
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@nl
P2093
P1476
Pharmacokinetics and pharmacod ...... agents: a comparative review.
@en
P2093
P304
P356
10.2165/00003088-200140030-00004
P577
2001-01-01T00:00:00Z
P6179
1041373421